✦ LIBER ✦

YPSP01-02 - Effectiveness, quality of life and changes in burden of disease in children and adolescents with ADHD transitioning to OROS MPH

✍ Scribed by Wolff, C.; Mattejat, F.; Dichter, S.; Schaeuble, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PW01-63 - Functionality and quality of l

✍ Niederkirchner, K.; Mattejat, F.; Dichter, S.; Schaeuble, B. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 28 KB

P01-166 - Transitioning onto OROS MPH is

✍ A. Alfred; A. Lindermueller; F. Mattejat; S. Dichter; B. Schaeuble 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 32 KB

P03-347 Transitioning onto OROS MPH is a

✍ A. Kordon; W. Hultzsch; F. Mattejat; S. Dichter; B. Schaeuble 📂 Article 📅 2010 🏛 Elsevier Science 🌐 French ⚖ 36 KB

Tolerability and effects of OROS®MPH (Co

✍ Martin Gerwe; Kirsten Stollhoff; Jacek Mossakowski; Hans-Juergen Kuehle; Ulrich 📂 Article 📅 2009 🏛 Springer Vienna 🌐 English ⚖ 304 KB

P.7.a.012 Effects of OROS methylphenidat

✍ A. Kesic; A. Lakic; D. Dronjak; D. Stupar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

The family impact in children and adoles

✍ Chou, W.J.; Wang, L.J.; Lin, C.H. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 64 KB